Literature DB >> 17952368

Protein kinase B: signalling roles and therapeutic targeting.

E M Sale1, G J Sale.   

Abstract

The serine/threonine kinase, protein kinase B (PKB, also known as Akt), is activated by a wide array of growth factors and insulin. PKB is a central player in the regulation of metabolism, apoptosis, transcription and the cell-cycle. PKB exists as three isoforms (alpha, beta and gamma) that may have unique as well as common functions within the cell. Deregulation of PKB is associated with several human diseases, including cancer, diabetes and schizophrenia. These findings underscore the medical relevance of the PKB pathway and make PKB an attractive drug target for the treatment of diseases that exhibit abnormal PKB signalling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17952368     DOI: 10.1007/s00018-007-7274-9

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  48 in total

1.  Nucleolar targeting of the chaperone hsc70 is regulated by stress, cell signaling, and a composite targeting signal which is controlled by autoinhibition.

Authors:  Piotr Bański; Hicham Mahboubi; Mohamed Kodiha; Sanhita Shrivastava; Cynthia Kanagaratham; Ursula Stochaj
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

Review 2.  Regulation of inositol 1,4,5-trisphosphate-induced Ca2+ release by reversible phosphorylation and dephosphorylation.

Authors:  Veerle Vanderheyden; Benoit Devogelaere; Ludwig Missiaen; Humbert De Smedt; Geert Bultynck; Jan B Parys
Journal:  Biochim Biophys Acta       Date:  2008-12-16

3.  Nutrient deprivation induces neuronal autophagy and implicates reduced insulin signaling in neuroprotective autophagy activation.

Authors:  Jessica E Young; Refugio A Martinez; Albert R La Spada
Journal:  J Biol Chem       Date:  2008-11-18       Impact factor: 5.157

4.  Akt recruits Dab2 to albumin endocytosis in the proximal tubule.

Authors:  Kelly Koral; Hui Li; Nandita Ganesh; Morris J Birnbaum; Kenneth R Hallows; Elif Erkan
Journal:  Am J Physiol Renal Physiol       Date:  2014-09-24

Review 5.  MicroRNAs in metabolic disease.

Authors:  Carlos Fernández-Hernando; Cristina M Ramírez; Leigh Goedeke; Yajaira Suárez
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02       Impact factor: 8.311

Review 6.  Role of AKT signaling in DNA repair and clinical response to cancer therapy.

Authors:  Qun Liu; Kristen M Turner; W K Alfred Yung; Kexin Chen; Wei Zhang
Journal:  Neuro Oncol       Date:  2014-05-07       Impact factor: 12.300

Review 7.  Molecular mechanism of insulin resistance in obesity and type 2 diabetes.

Authors:  Kangduk Choi; Young-Bum Kim
Journal:  Korean J Intern Med       Date:  2010-06-01       Impact factor: 3.165

8.  AMPK-induced activation of Akt by AICAR is mediated by IGF-1R dependent and independent mechanisms in acute lymphoblastic leukemia.

Authors:  Gilles M Leclerc; Guy J Leclerc; Guilian Fu; Julio C Barredo
Journal:  J Mol Signal       Date:  2010-09-23

9.  Discovery of 4-amino-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamides as selective, orally active inhibitors of protein kinase B (Akt).

Authors:  Tatiana McHardy; John J Caldwell; Kwai-Ming Cheung; Lisa J Hunter; Kevin Taylor; Martin Rowlands; Ruth Ruddle; Alan Henley; Alexis de Haven Brandon; Melanie Valenti; Thomas G Davies; Lynsey Fazal; Lisa Seavers; Florence I Raynaud; Suzanne A Eccles; G Wynne Aherne; Michelle D Garrett; Ian Collins
Journal:  J Med Chem       Date:  2010-03-11       Impact factor: 7.446

10.  Inhibition of O-GlcNAcase using a potent and cell-permeable inhibitor does not induce insulin resistance in 3T3-L1 adipocytes.

Authors:  Matthew S Macauley; Yuan He; Tracey M Gloster; Keith A Stubbs; Gideon J Davies; David J Vocadlo
Journal:  Chem Biol       Date:  2010-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.